Evaluation of Breast Cancer Risk in a Multigenic Model Including Low Penetrance Genes Involved in Xenobiotic and Estrogen Metabolisms

REFERENCES

• Parkin , D M . 2004 . International variation . Oncogene , 23 : 6329 – 6340 .
   PubMed Web of Science ®Google Scholar
• de Jong , M M , Nolte , I M , te Meerman , G J , van der Graaf , W T Oosterwijk , J C . 2002 . Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility . J Med Genet , 39 : 225 – 242 .
   PubMed Web of Science ®Google Scholar
• Dunning , A M , Healey , C S , Pharoah , P D , Teare , M D Ponder , B A . 1999 . A systematic review of genetic polymorphisms and breast cancer risk . Cancer Epidemiol Biomarkers Prev , 8 : 843 – 854 .
   PubMed Web of Science ®Google Scholar
• Dumitrescu , R G and Cotarla , I . 2005 . Understanding breast cancer risk—where do we stand in 2005? . J Cell Mol Med , 9 : 208 – 221 .
   PubMed Web of Science ®Google Scholar
• Cheng , T C , Chen , S T , Huang , C S , Fu , Y P Yu , J C . 2005 . Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility . Int J Cancer , 113 : 345 – 353 .
   PubMed Web of Science ®Google Scholar
• Mitrunen , K and Hirvonen , A . 2003 . Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in estrogen biosynthesis and metabolism . Mutat Res , 544 : 9 – 41 .
   PubMed Web of Science ®Google Scholar
• Junien , C . 2001 . Evaluation du risque de cancer du sein à l'aide d'un modèle multigénique constituté de gènes de faible pénétrance impliqués dans les metabolismes des xénobiotique et des oestrogènes. [Colon cancer and nutritional genetics: modifier genes] . Ann Med Interne (Paris) , 152 : 337 – 351 .
   PubMedGoogle Scholar
• Sinha , R and Caporaso , N . 1999 . Diet, genetic susceptibility and human cancer etiology . J Nutr , 129 : 556S – 559S .
   PubMed Web of Science ®Google Scholar
• Hein , D W . 2002 . Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis . Mutat Res , 506–507 : 65 – 77 .
   PubMed Web of Science ®Google Scholar
• Hein , D W , Doll , M A , Fretland , A J , Leff , M A Webb , S J . 2000 . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms . Cancer Epidemiol Biomarkers Prev , 9 : 29 – 42 .
   PubMed Web of Science ®Google Scholar
• Dawling , S , Roodi , N , Mernaugh , R L , Wang , X and Parl , F F . 2001 . Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms . Cancer Res , 61 : 6716 – 6722 .
   PubMed Web of Science ®Google Scholar
• Livak , K J . 1999 . Allelic discrimination using fluorogenic probes and the 5' nuclease assay . Genet Anal , 14 : 143 – 149 .
   PubMedGoogle Scholar
• Kwiatkowski , F , Girard , M , Hacène , K and Berlie , J . 2000 . SEM: a suitable statistical software adapted for research in oncology . Bull Cancer , 87 : 715 – 721 .
   PubMed Web of Science ®Google Scholar
• Crofts , F , Taioli , E , Trachman , J , Cosma , G N Currie , D . 1994 . Functional significance of different human CYP1A1 genotypes . Carcinogenesis , 15 : 2961 – 2963 .
   PubMed Web of Science ®Google Scholar
• Hanna , I H , Dawling , S , Roodi , N , Guengerich , F P and Parl , F F . 2000 . Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity . Cancer Res , 60 : 3440 – 3444 .
   PubMed Web of Science ®Google Scholar
• Ishibe , N , Hankinson , S E , Colditz , G A , Spiegelman , D Willett , W C . 1998 . Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study . Cancer Res , 58 : 667 – 671 .
   PubMed Web of Science ®Google Scholar
• Rebbeck , T R , Rosvold , E A , Duggan , D J , Zhang , J and Buetow , K H . 1994 . Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer . Cancer Epidemiol Biomarkers Prev , 3 : 511 – 514 .
   PubMed Web of Science ®Google Scholar
• Zhang , Y , Wise , J P , Holford , T R , Xie , H Boyle , P . 2004 . Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women . Am J Epidemiol , 160 : 1177 – 1183 .
   PubMed Web of Science ®Google Scholar
• da Fonte de Amorim , L , Rossini , A , Mendonca , G , Lotsch , P de Almeida Simao , T . 2002 . CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women . Cancer Lett , 181 : 179 – 186 .
   PubMed Web of Science ®Google Scholar
• Krajinovic , M , Ghadirian , P , Richer , C , Sinnett , H Gandini , S . 2001 . Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene–environment interactions . Int J Cancer , 92 : 220 – 225 .
   PubMed Web of Science ®Google Scholar
• Miyoshi , Y and Noguchi , S . 2003 . Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women . Biomed Pharmacother , 57 : 471 – 481 .
   PubMed Web of Science ®Google Scholar
• Boyapati , S M , Shu , X O , Gao , Y T , Cai , Q Jin , F . 2005 . Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women . Cancer , 103 : 2228 – 2235 .
   PubMed Web of Science ®Google Scholar
• Bailey , L R , Roodi , N , Dupont , W D and Parl , F F . 1998 . Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer . Cancer Res , 58 : 5038 – 5041 .
   PubMed Web of Science ®Google Scholar
• De Vivo , I , Hankinson , S E , Li , L , Colditz , G A and Hunter , D J . 2002 . Association of CYP1B1 polymorphisms and breast cancer risk . Cancer Epidemiol Biomarkers Prev , 11 : 489 – 492 .
   PubMed Web of Science ®Google Scholar
• Rylander-Rudqvist , T , Wedren , S , Granath , F , Humphreys , K Ahlberg , S . 2003 . Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk . Carcinogenesis , 24 : 1533 – 1539 .
   PubMed Web of Science ®Google Scholar
• Dunning , A M , Dowsett , M , Healey , C S , Tee , L Luben , R N . 2004 . Polymorphisms associated with circulating sex hormone levels in postmenopausal women . J Natl Cancer Inst , 96 : 936 – 945 .
   PubMed Web of Science ®Google Scholar
• Lee , K M , Abel , J , Ko , Y , Harth , V Park , W Y . 2003 . Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women . Br J Cancer , 88 : 675 – 678 .
   PubMed Web of Science ®Google Scholar
• Thyagarajan , B , Brott , M , Mink , P , Folsom , A R Anderson , K E . 2004 . CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study . Cancer Lett , 207 : 183 – 189 .
   PubMed Web of Science ®Google Scholar
• Zheng , W , Xie , D W , Jin , F , Cheng , J R Dai , Q . 2000 . Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer . Cancer Epidemiol Biomarkers Prev , 9 : 147 – 150 .
   PubMed Web of Science ®Google Scholar
• Watanabe , J , Shimada , T , Gillam , E M , Ikuta , T Suemasu , K . 2000 . Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer . Pharmacogenetics , 10 : 25 – 33 .
   PubMedGoogle Scholar
• Kocabas , N A , Sardas , S , Cholerton , S , Daly , A K and Karakaya , A E . 2002 . Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population . Arch Toxicol , 76 : 643 – 649 .
   PubMed Web of Science ®Google Scholar
• Huang , C S , Chern , H D , Chang , K J , Cheng , C W Hsu , S M . 1999 . Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility . Cancer Res , 59 : 4870 – 4875 .
   PubMed Web of Science ®Google Scholar
• Huang , Z , Fasco , M J , Figge , H L , Keyomarsi , K and Kaminsky , L S . 1996 . Expression of cytochromes P450 in human breast tissue and tumors . Drug Metab Dispos , 24 : 899 – 905 .
   PubMed Web of Science ®Google Scholar
• Helzlsouer , K J , Selmin , O , Huang , H Y , Strickland , P T Hoffman , S . 1998 . Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer . J Natl Cancer Inst , 90 : 512 – 518 .
   PubMed Web of Science ®Google Scholar
• Ballard-Barbash , R . 1994 . Anthropometry and breast cancer: body size—a moving target . Cancer , 74 : 1090 – 1100 .
   PubMed Web of Science ®Google Scholar
• Mannisto , S , Pietinen , P , Pyy , M , Palmgren , J Eskelinen , M . 1996 . Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status . Int J Cancer , 68 : 8 – 13 .
   PubMed Web of Science ®Google Scholar
• Huang , Z , Willett , W C , Colditz , G A , Hunter , D J Manson , J E . 1999 . Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study . Am J Epidemiol , 150 : 1316 – 1324 .
   PubMed Web of Science ®Google Scholar